Eugene Sefanov

Medication non-adherence continues to be a big issue in the pharma industry, affecting clinical outcomes for both approved and investigational drugs. Sponsors, research organizations, and payers are looking to verify that what they’re studying or paying for is actually being used as directed. Various technologies, such as Proteus and AiCure, are being examined for these […]

  As we mentioned in our life sciences trends guide for 2016, patient recruitment is a constant challenge that needs to be confronted head-on with innovative tactics and technology. The mere fact that only 5% of cancer patients ever enroll in a trial is simply unacceptable, considering how connected we are in the digital era. 

  In “fun” news, the FDA wants to know if the use of animation in pharmaceutical advertising affects consumers’ general perception of drugs, as well as the side effects they can cause. According to a Notice posted on the Federal Register website, the FDA is looking to answer the following questions: 

  Multiple Myeloma Research Foundation (MMRF) founder Kathy Giusti attended the Precision Medicine Initiative (PMI) summit several weeks ago, which was hosted by President Barack Obama. In a Forbes guest post, she shared five reasons why we can be optimistic about the initiative, which aims to develop better, targeted therapies that leverages one’s unique genetic […]

  When J.P. Morgan speaks, most financial institutions listen. A recent Wall Street Journal article outlined the US bank’s $9.4 billion technology spending plan, 40% of which will be allocated to new investments and technology. While new investments and technology are essential, part of the company’s plan is to also trim excess cost. 

  ExxonMobil, the largest publicly traded international oil and gas company, is now leveraging the cloud in a revolutionary way: With ExxonMobil’s new Speedpass+ app, you can pay for gas at Exxon- and Mobil-branded locations using Apple Pay, a simple and safe way to pay within the app. Just open the app and your location […]

  If you’re a follower of our blog, you probably know that I enjoy listening to earnings conference calls. They give you a rare look into a company’s operational successes, and sometimes failures. Just last month, Quintiles held their Q4 2015 Earnings Call, which was full of information that gives color not only to the […]

  The life sciences industry is truly a global marketplace. Companies reside all over the map, and now more than ever, pharmaceutical companies and contract research organizations are choosing to move their headquarters overseas, to places like Ireland, where they are more tax-friendly. Whether born and bred in Ireland or a recent transplant, the island […]

  It’s that time of year again. The event for industry thought leaders and decision makers is just around the corner, and we’re hoping you’ll attend. Even if you can’t attend, we’re still giving you the opportunity to enter to win a SONOS wireless speaker…just because we like you. 

  Booz Allen Hamilton, a management and technology consulting firm, believes that hyper-personalization, the ability to leverage analytics and other digital methods to communicate on a one-to-one level, will be a trend for 2016. We agree. For example, portals will offer patients and their caretakers the information they want when they want it. 

  “There are as many types of lung cancer as there are patients with lung cancer. We now understand lung cancer is unique to each patient and tailored treatments are more effective and less toxic. With the rapid developments being made in targeted treatment options available to patients with lung cancer, chemotherapy, radiation and surgery […]

  A 2015 article in The Huffington Post talked about some of the challenges of clinical supply management. The author, Loretta Cipkus Dubray of Global Clinical Connections, listed four issues: counterfeiting, technology, weather conditions, and local government/politics. Naturally, the technology bit caught my attention.